MeSH term
Frequency | Condition_Probility | Female | 35 | 0.0 |
Humans | 63 | 0.0 |
Mutation | 4 | 0.0 |
Animals | 28 | 0.0 |
Comparative Study | 3 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
High Mobility Group Proteins/genetics | 2 | 5.0 |
Research Support, Non-U.S. Gov't | 24 | 0.0 |
*Sex Determination (Genetics) | 3 | 5.0 |
Sex Differentiation/*genetics | 2 | 7.0 |
Transcription Factors/genetics | 2 | 0.0 |
Gene Expression | 4 | 0.0 |
Gene Expression Regulation, Developmental | 3 | 0.0 |
Male | 50 | 0.0 |
Sertoli Cells/metabolism | 5 | 25.0 |
Testicular Hormones/*genetics | 4 | 28.0 |
Animals, Newborn | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 4 | 0.0 |
*Glycoproteins | 38 | 4.0 |
Immunohistochemistry | 5 | 0.0 |
Mice | 11 | 0.0 |
Organ Culture Techniques | 4 | 1.0 |
Growth Inhibitors/*genetics | 3 | 6.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Receptors, Peptide/*genetics | 2 | 9.0 |
Semen/metabolism | 2 | 18.0 |
Adolescent | 13 | 0.0 |
Child | 16 | 0.0 |
Child, Preschool | 16 | 0.0 |
Chorionic Gonadotropin/pharmacology | 3 | 2.0 |
Follicle Stimulating Hormone/blood | 4 | 0.0 |
Infant | 16 | 0.0 |
Karyotyping | 2 | 0.0 |
Leydig Cells/physiology | 2 | 15.0 |
Luteinizing Hormone/blood | 5 | 0.0 |
Sertoli Cells/physiology | 4 | 28.0 |
Testicular Hormones/blood | 2 | 50.0 |
Testosterone/blood | 6 | 1.0 |
Growth Inhibitors/*analysis | 2 | 15.0 |
Testicular Hormones/*analysis | 3 | 75.0 |
Homozygote | 2 | 0.0 |
Phenotype | 2 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Receptors, Peptide/genetics | 2 | 25.0 |
Adult | 13 | 0.0 |
Growth Inhibitors/*blood | 7 | 36.0 |
Reference Values | 6 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Testicular Hormones/*blood | 13 | 100.0 |
Amino Acid Sequence | 6 | 0.0 |
Base Sequence | 7 | 0.0 |
*Gene Expression Regulation, Developmental | 2 | 0.0 |
Molecular Sequence Data | 9 | 0.0 |
Mullerian Ducts/embryology | 2 | 100.0 |
Testis/embryology | 2 | 9.0 |
Transcription Factors/*genetics | 2 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Fetus/metabolism | 4 | 2.0 |
Growth Inhibitors/*metabolism | 3 | 5.0 |
Testicular Hormones/*metabolism | 4 | 66.0 |
Gonadotropins/*deficiency | 2 | 33.0 |
Middle Aged | 3 | 0.0 |
Infant, Newborn | 9 | 0.0 |
Puberty | 2 | 2.0 |
Cell Line | 2 | 0.0 |
Follicle Stimulating Hormone/pharmacology | 2 | 3.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Rats | 7 | 0.0 |
Signal Transduction/*physiology | 4 | 0.0 |
Glycoproteins/*blood | 4 | 5.0 |
Inhibins/*blood | 3 | 27.0 |
Pregnancy | 4 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Pseudohermaphroditism/*genetics | 2 | 14.0 |
Syndrome | 4 | 0.0 |
Mullerian Ducts/physiology | 2 | 100.0 |
Inhibins/blood | 2 | 22.0 |
Predictive Value of Tests | 2 | 0.0 |
Prognosis | 2 | 0.0 |
Puberty/physiology | 2 | 13.0 |
Gene Expression Regulation | 3 | 0.0 |
DNA Primers | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 2 | 0.0 |
*Nuclear Proteins | 2 | 0.0 |
Testicular Hormones/genetics | 2 | 50.0 |
Puberty, Delayed/blood | 3 | 75.0 |
Testosterone/physiology | 2 | 40.0 |
English Abstract | 5 | 0.0 |
Aging/blood | 3 | 5.0 |
Drug Resistance | 2 | 0.0 |
Pseudohermaphroditism/blood | 2 | 100.0 |
Age Factors | 2 | 0.0 |
Cryptorchidism/blood | 2 | 66.0 |
Growth Inhibitors/*blood/physiology | 2 | 100.0 |
Testicular Hormones/*blood/physiology | 2 | 100.0 |
Cloning, Molecular | 3 | 0.0 |
Exons | 2 | 0.0 |
*Mullerian Ducts | 3 | 100.0 |
*Mutation | 2 | 0.0 |
Binding Sites | 2 | 0.0 |
CHO Cells | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Androgens/physiology | 2 | 4.0 |
Biological Markers/blood | 6 | 0.0 |
Ovarian Follicle/ultrasonography | 2 | 50.0 |
Sex Differentiation | 3 | 13.0 |
Cattle | 3 | 0.0 |
Depression, Chemical | 2 | 1.0 |
Species Specificity | 2 | 0.0 |
Glycoproteins/*physiology | 2 | 3.0 |
Models, Biological | 2 | 0.0 |
Sex Differentiation/physiology | 4 | 44.0 |
Testicular Hormones/*physiology | 3 | 75.0 |
Trans-Activators/*physiology | 2 | 0.0 |
Fertilization in Vitro | 2 | 1.0 |
Follicle Stimulating Hormone/physiology | 3 | 25.0 |
Mice, Knockout | 3 | 0.0 |
Ovary/*physiology | 3 | 8.0 |
Fetus | 2 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 3 | 0.0 |
Mullerian Ducts/*physiology | 2 | 66.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
*Growth Inhibitors | 3 | 5.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Sex Determination (Genetics) | 2 | 5.0 |
Prospective Studies | 2 | 0.0 |
